HIF-1alpha: a valid therapeutic target for tumor therapy
about
Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer CellsAryl Hydrocarbon Receptor Activates NDRG1 Transcription under Hypoxia in Breast Cancer CellsBetter Living through Chemistry: Caloric Restriction (CR) and CR Mimetics Alter Genome Function to Promote Increased Health and LifespanBile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell modelsThe clinicopathological significance of tissue levels of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in gastric cancer.Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing.The role of hypoxia inducible factor-1 in hepatocellular carcinoma.Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules.Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus.A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.HIF-1α contributes to proliferation and invasiveness of neuroblastoma cells via SHH signaling.Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degenerationFolic Acid Represses Hypoxia-Induced Inflammation in THP-1 Cells through Inhibition of the PI3K/Akt/HIF-1α PathwayClinicopathological Significance of MicroRNA-20b Expression in Hepatocellular Carcinoma and Regulation of HIF-1α and VEGF Effect on Cell Biological Behaviour.Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1.[18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.Hypoxia Positively Regulates the Expression of pH-Sensing G-Protein-Coupled Receptor OGR1 (GPR68)The influence of pH and hypoxia on tumor metastasis.Exploring the modulation of hypoxia-inducible factor (HIF)-1α by volatile anesthetics as a possible mechanism underlying volatile anesthetic-induced CNS injury.Nuclear translocation of HIF-1α induced by influenza A (H1N1) infection is critical to the production of proinflammatory cytokinesTranscriptional regulation of human and murine short-chain dehydrogenase/reductases (SDRs) - an in silico approach.Transcriptome sequencing revealed differences in the response of renal cancer cells to hypoxia and CoCl 2 treatment.Hypoxia-Inducible Factor-1α in Antarctic notothenioids contains a polyglutamine and glutamic acid insert that varies in length with phylogeny.BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation.Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography.Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review.
P2860
Q26798203-545F7E45-7E6C-48AE-A1A5-38C9BB3F5F9BQ27349970-AA801679-1864-49A9-B06E-676B2E16574FQ28073173-26C343F6-C35C-4E15-A1B5-49968B7E043DQ28596213-8709AF0D-932B-4AD1-9093-E063D65A8AB5Q33781573-6EEAC5C4-6DFA-4EE5-8645-672724AEAED7Q33799828-7BD5AE01-E997-4131-8DE6-C1D0C5DAC49CQ33914603-6539B288-301E-491C-BC7C-B32690F27531Q33940076-75662267-2BED-4035-8F24-B6D4314EEFF5Q33960155-83CE09BE-EDB6-499C-8ABF-89AB2B024E1EQ34476578-17159565-ADAC-4440-8A45-E0D8BF76DA83Q34577475-775BE0F3-0AA3-4D5F-8AC7-99D4C45D2E10Q35587212-45F7E975-C93B-49DF-98C2-CB0B6F93D5B8Q35596135-16EBF71F-836A-497D-AB3D-369217BCF761Q35955970-3890B520-7949-48EB-AFD6-4D54C157022DQ36285231-7D387808-94CA-4836-813F-C2951E30BB5BQ36482596-E60B09DD-9402-494A-9381-02025C5A68F5Q36901233-93101C1B-2E60-4C5A-8A97-103A2AC4E8B5Q37594838-317E617F-0D28-486B-9F51-8B2AD1C79970Q38149984-EB01B1A2-3EBD-43DA-A248-40B93D2FEA0DQ38227466-801F0C47-235F-4810-8BA2-C3B1B6E1DC2DQ38768252-1B9C8079-D09D-449E-9EA6-695330E3969FQ39642939-0ABD7582-662A-48ED-B45E-BC099C9CCD23Q41808602-EC2069EF-DABF-49DA-98A3-B8AA10C2003DQ50074081-A3673B2A-9AAF-435B-8DA0-D4886A9F0DF8Q52882453-EDBD7CC9-D391-402B-8D24-07E841C533BAQ54340369-DD6FEA85-546C-4555-93D5-AF7F13CC133FQ54969538-AD21D737-06EE-488B-8AB8-2F3B7478B9DD
P2860
HIF-1alpha: a valid therapeutic target for tumor therapy
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
HIF-1alpha: a valid therapeutic target for tumor therapy
@ast
HIF-1alpha: a valid therapeutic target for tumor therapy
@en
type
label
HIF-1alpha: a valid therapeutic target for tumor therapy
@ast
HIF-1alpha: a valid therapeutic target for tumor therapy
@en
prefLabel
HIF-1alpha: a valid therapeutic target for tumor therapy
@ast
HIF-1alpha: a valid therapeutic target for tumor therapy
@en
P2093
P2860
P1476
HIF-1alpha: a valid therapeutic target for tumor therapy
@en
P2093
Hyunseung Lee
Kyu-Won Kim
Soon-Sun Hong
P2860
P304
P356
10.4143/CRT.2004.36.6.343
P577
2004-12-31T00:00:00Z